Procter & Gamble Health Limited
NSE: PGHL BSE: PGHL
NSE
6,243.50
-88.50 (-1.40%)
Prev Close
6332
Open Price
6371
Volume
6,067
Today Low / High
6222 / 6371
52 WK Low / High
4863 / 6739
Range
5,931 - 6,556
BSE
6,256.25
-84.90 (-1.34%)
Prev Close
6341.15
Open Price
6342.9
Volume
848
Today Low / High
6226.55 / 6348
52 WK Low / High
4912.3 / 6700
Range
5,943 - 6,569
The stock is currently trading on both the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE). On the NSE, the stock is priced at 6243.5 (target range: 5,931 - 6,556), reflecting a change of -88.5 (-1.39766%). On the BSE, it is listed at 6256.25 (target range: 5,943 - 6,569), showing a change of -84.9 (-1.33887%). The stock price is currently in decline on both exchanges, signaling a downtrend. If you're considering investing in this stock, it's important to monitor the situation closely.
12 Sep
6,371.00
-2.00%
11 Sep
6,330.00
0.03%
10 Sep
6,500.00
-2.62%
09 Sep
6,528.00
-0.81%
08 Sep
6,505.50
0.35%
05 Sep
6,437.00
0.43%
04 Sep
6,317.50
2.29%
03 Sep
6,315.50
0.02%
02 Sep
6,311.00
0.33%
01 Sep
6,340.00
-0.46%
29 Aug
6,606.00
-3.57%
28 Aug
6,310.00
-0.18%
26 Aug
6,400.50
-1.41%
25 Aug
6,581.50
-2.55%
22 Aug
6,300.00
4.47%
21 Aug
6,320.00
0.29%
20 Aug
6,300.00
-0.23%
19 Aug
6,273.50
0.28%
18 Aug
6,408.00
-2.88%
Procter & Gamble Health Limited Graph
Procter & Gamble Health Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for Procter & Gamble Health Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 6,243.50, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 6,256.25 | 6,318.81 | 5,686.93 - 6,950.69 |
| 6,381.38 | 5,105.10 - 7,657.65 | ||
| 6,443.94 | 4,510.76 - 8,377.12 | ||
| Bearish Scenario | 6,256.25 | 6,193.69 | 5,574.32 - 6,813.06 |
| 6,131.13 | 4,904.90 - 7,357.35 | ||
| 6,068.56 | 4,247.99 - 7,889.13 |
Overview of Procter & Gamble Health Limited
ISIN
INE199A01012
Industry
Drug Manufacturers - Specialty & Generic
Vol.Avg
16,882
Market Cap
103,638,353,900
Last Dividend
125
Official Website
IPO Date
2002-07-01
DCF Diff
-2,445.29
DCF
8,689
Financial Ratios Every Investor Needs
Stock Dividend of PGHL
| Date | Label | Adj Dividend | Dividend | Record Date | Payment Date | Declaration Date |
|---|---|---|---|---|---|---|
| 2025-08-22 | August 22, 25 | 45 | 45 | 2025-08-22 | 2025-09-25 | |
| 2025-02-21 | February 21, 25 | 80 | 80 | 2025-02-21 | 2025-03-07 | |
| 2024-11-28 | November 28, 24 | 60 | 60 | 2024-11-28 | 2024-12-25 | |
| 2024-02-14 | February 14, 24 | 200 | 200 | 2024-02-14 | 2024-03-03 | |
| 2023-11-23 | November 23, 23 | 50 | 50 | 2023-11-23 | 2023-12-30 |
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 1,245.56 Cr | 561.67 Cr | 683.89 Cr | 0.5491 | 0.00 Cr | 0.00 Cr | 402.27 Cr | 312.55 Cr | 188.29 | 438.32 Cr | 0.2509 |
| 2024-06-30 | 1,151.26 Cr | 330.56 Cr | 820.70 Cr | 0.7129 | 0.00 Cr | 0.00 Cr | 606.98 Cr | 200.98 Cr | 121.07 | 307.44 Cr | 0.1746 |
| 2023-06-30 | 1,229.62 Cr | 361.84 Cr | 867.78 Cr | 0.7057 | 5.71 Cr | 148.17 Cr | 314.24 Cr | 229.47 Cr | 138.24 | 342.72 Cr | 0.1866 |
| 2022-06-30 | 1,092.04 Cr | 367.11 Cr | 724.93 Cr | 0.6638 | 6.55 Cr | 23.32 Cr | 260.31 Cr | 192.52 Cr | 115.98 | 280.52 Cr | 0.1763 |
| 2021-06-30 | 990.79 Cr | 339.27 Cr | 651.52 Cr | 0.6576 | 3.93 Cr | 47.43 Cr | 234.98 Cr | 176.80 Cr | 106.51 | 263.77 Cr | 0.1784 |
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 188.55 Cr | 794.20 Cr | 257.24 Cr | 536.9600 Cr | 7.62 Cr | -180.93 Cr | 109.37 Cr | 121.99 Cr | 0.00 Cr | 0.00 Cr | 19.33 Cr | 215.3100 Cr |
| 2024-06-30 | 244.36 Cr | 794.36 Cr | 256.12 Cr | 538.2400 Cr | 9.56 Cr | -234.80 Cr | 109.11 Cr | 131.53 Cr | 0.00 Cr | 0.00 Cr | 11.64 Cr | 218.9100 Cr |
| 2023-06-30 | 435.05 Cr | 1,101.19 Cr | 350.30 Cr | 750.8900 Cr | 12.00 Cr | -423.05 Cr | 134.94 Cr | 173.27 Cr | 54.82 Cr | 0.00 Cr | -12.64 Cr | 303.9000 Cr |
| 2022-06-30 | 319.40 Cr | 893.72 Cr | 277.23 Cr | 616.4900 Cr | 2.83 Cr | -316.57 Cr | 115.21 Cr | 149.62 Cr | 0.56 Cr | 0.00 Cr | -3.83 Cr | 235.8300 Cr |
| 2021-06-30 | 464.05 Cr | 986.16 Cr | 282.45 Cr | 703.7100 Cr | 7.61 Cr | -456.44 Cr | 118.37 Cr | 140.13 Cr | 97.22 Cr | 0.00 Cr | -2.66 Cr | 238.9700 Cr |
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 175.8400 Cr | 2.4400 Cr | -234.7400 Cr | 167.2800 Cr | -251.6700 Cr | 188.5500 Cr | -8.5600 Cr | 312.5459 Cr | 0.0000 Cr | -232.4000 Cr | -2.3700 Cr |
| 2024-06-30 | 228.2800 Cr | -6.8700 Cr | -418.1100 Cr | 206.5600 Cr | -196.6900 Cr | 238.7300 Cr | -21.7300 Cr | 200.9800 Cr | 0.0000 Cr | -414.9900 Cr | 23.1300 Cr |
| 2023-06-30 | 236.0000 Cr | -21.5000 Cr | -98.4700 Cr | 193.5200 Cr | 116.0200 Cr | 435.4200 Cr | -42.4800 Cr | 314.2000 Cr | 0.0000 Cr | -93.7900 Cr | -32.3900 Cr |
| 2022-06-30 | 169.5200 Cr | -25.5400 Cr | -288.6300 Cr | 131.6000 Cr | -144.6500 Cr | 319.4000 Cr | -37.9200 Cr | 253.3700 Cr | 0.0000 Cr | -283.8500 Cr | -2.0200 Cr |
| 2021-06-30 | 247.2600 Cr | -32.2700 Cr | -386.6300 Cr | 194.6800 Cr | -171.6400 Cr | 464.0500 Cr | -52.5800 Cr | 233.2800 Cr | 0.0000 Cr | -381.7800 Cr | 15.2600 Cr |
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2025-06-30 | 338.74 Cr | 155.44 Cr | 183.30 Cr | 0.5411 | 84.90 Cr | 66.18 Cr | 39.87 | 94.37 Cr | 0.1954 |
| 2025-03-31 | 310.99 Cr | 98.72 Cr | 212.27 Cr | 0.6826 | 75.55 Cr | 61.18 Cr | 36.86 | 84.03 Cr | 0.1967 |
| 2024-12-31 | 309.77 Cr | 75.73 Cr | 234.04 Cr | 0.7555 | 117.88 Cr | 90.90 Cr | 54.76 | 127.39 Cr | 0.2934 |
| 2024-09-30 | 313.41 Cr | 140.04 Cr | 173.37 Cr | 0.5532 | 108.27 Cr | 82.33 Cr | 49.60 | 117.32 Cr | 0.2627 |
| 2024-06-30 | 283.88 Cr | 134.96 Cr | 148.92 Cr | 0.5246 | 41.09 Cr | 16.78 Cr | 10.11 | 30.19 Cr | 0.0591 |
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 182.08 Cr | 23.98 Cr | 206.06 Cr | 146.99 Cr | 109.37 Cr | 526.39 Cr | 121.99 Cr | 794.20 Cr | 257.24 Cr |
| 2024-12-31 | 266.43 Cr | 25.83 Cr | 292.26 Cr | 132.24 Cr | 118.78 Cr | 612.49 Cr | 125.27 Cr | 870.15 Cr | 259.69 Cr |
| 2024-09-30 | 0.00 Cr | 0.00 Cr | 244.36 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -538.24 Cr |
| 2024-06-30 | 244.36 Cr | 0.00 Cr | 244.36 Cr | 85.33 Cr | 109.11 Cr | 524.22 Cr | 131.53 Cr | 794.36 Cr | 256.12 Cr |
| 2024-03-31 | -425.56 Cr | 851.12 Cr | 425.56 Cr | 0.00 Cr | 0.00 Cr | 425.56 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 78.53 Cr | 49.22 Cr | -0.05 Cr | -133.58 Cr | -84.41 Cr | 182.27 Cr | 266.68 Cr | -3.23 Cr | 45.99 Cr |
| 2024-12-31 | 90.90 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-09-30 | 82.33 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-06-30 | 16.78 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-03-31 | 46.56 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| No split history data available. | ||
Similar Stocks: Drug Manufacturers - Specialty & Generic
| Company Name | Symbol | Price | Market Cap | Volume |
|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | SUNPHARMA | ₹1,616.60 | ₹3,878,676,048,000.00 | ₹1,878,887.00 |
| Divi's Laboratories Limited | DIVISLAB | ₹6,026.50 | ₹1,599,848,928,500.00 | ₹487,570.00 |
| Torrent Pharmaceuticals Limited | TORNTPHARM | ₹3,566.20 | ₹1,206,962,559,000.00 | ₹139,352.00 |
| Dr. Reddy's Laboratories Limited | DRREDDY | ₹1,316.70 | ₹1,095,964,560,653.00 | ₹1,042,670.00 |
| Mankind Pharma Limited | MANKIND | ₹2,579.60 | ₹1,064,750,578,074.00 | ₹181,489.00 |
| Zydus Lifesciences Limited | ZYDUSLIFE | ₹1,044.75 | ₹1,051,258,792,500.00 | ₹559,507.00 |
| Lupin Limited | LUPIN | ₹2,043.40 | ₹933,333,167,000.00 | ₹1,611,273.00 |
| Alkem Laboratories Limited | ALKEM | ₹5,448.00 | ₹651,390,120,000.00 | ₹120,660.00 |
| Aurobindo Pharma Limited | AUROPHARMA | ₹1,094.40 | ₹635,629,708,800.00 | ₹793,814.00 |
| Glenmark Pharmaceuticals Limited | GLENMARK | ₹2,132.50 | ₹601,793,632,500.00 | ₹615,366.00 |
| Laurus Labs Limited | LAURUSLABS | ₹896.05 | ₹483,710,191,250.00 | ₹1,298,692.00 |
| Suven Pharmaceuticals Limited | SUVENPHAR | ₹1,078.00 | ₹412,407,234,624.00 | ₹1,177,218.00 |
| Cohance Lifesciences Limited | COHANCE | ₹980.40 | ₹375,068,694,643.00 | ₹176,773.00 |
| Ipca Laboratories Limited | IPCALAB | ₹1,314.80 | ₹333,570,019,200.00 | ₹237,352.00 |
| Ajanta Pharma Limited | AJANTPHARM | ₹2,579.10 | ₹322,222,437,600.00 | ₹58,260.00 |
| J. B. Chemicals & Pharmaceuticals Limited | JBCHEPHARM | ₹1,699.90 | ₹266,197,540,400.00 | ₹56,240.00 |
| Wockhardt Limited | WOCKPHARMA | ₹1,518.00 | ₹246,651,927,918.00 | ₹287,476.00 |
| Piramal Enterprises Limited | PEL | ₹1,083.70 | ₹245,650,948,600.00 | ₹565,474.00 |
| Eris Lifesciences Limited | ERIS | ₹1,675.90 | ₹228,269,311,300.00 | ₹711,885.00 |
| AstraZeneca Pharma India Limited | ASTRAZEN | ₹9,003.50 | ₹225,087,500,000.00 | ₹7,058.00 |
| Neuland Laboratories Limited | NEULANDLAB | ₹16,049.00 | ₹205,907,065,100.00 | ₹157,007.00 |
| Alembic Pharmaceuticals Limited | APLLTD | ₹946.50 | ₹186,046,879,500.00 | ₹132,074.00 |
| Jubilant Pharmova Limited | JUBLPHARMA | ₹1,122.30 | ₹178,761,066,300.00 | ₹82,149.00 |
| Caplin Point Laboratories Limited | CAPLIPOINT | ₹2,245.60 | ₹170,691,873,520.00 | ₹78,387.00 |
| NATCO Pharma Limited | NATCOPHARM | ₹862.20 | ₹154,428,642,000.00 | ₹287,000.00 |
| Glenmark Life Sciences Limited | GLS | ₹1,086.00 | ₹133,070,838,000.00 | ₹130,938.00 |
| Granules India Limited | GRANULES | ₹534.35 | ₹129,656,821,400.00 | ₹1,274,862.00 |
| Procter & Gamble Health Limited | PGHL | ₹6,243.50 | ₹103,638,353,900.00 | ₹6,067.00 |
| Aarti Pharmalabs Limited | AARTIPHARM | ₹926.35 | ₹83,957,850,833.00 | ₹170,096.00 |
| Strides Pharma Science Limited | STAR | ₹909.75 | ₹83,854,113,825.00 | ₹182,119.00 |
| Shilpa Medicare Limited | SHILPAMED | ₹827.60 | ₹80,931,748,840.00 | ₹90,322.00 |
| FDC Limited | FDC | ₹463.35 | ₹75,438,013,500.00 | ₹27,055.00 |
| Innova Captab Limited | INNOVACAP | ₹859.60 | ₹49,190,549,828.00 | ₹33,571.00 |
| Suven Life Sciences Limited | SUVEN | ₹224.63 | ₹48,978,481,767.00 | ₹179,307.00 |
| Aarti Drugs Limited | AARTIDRUGS | ₹509.65 | ₹46,515,755,500.00 | ₹129,437.00 |
| Sun Pharma Advanced Research Company Limited | SPARC | ₹143.10 | ₹46,439,098,200.00 | ₹131,426.00 |
| Sequent Scientific Limited | SEQUENT | ₹182.51 | ₹45,688,640,850.00 | ₹212,635.00 |
| RPG Life Sciences Limited | RPGLIFE | ₹2,380.30 | ₹39,367,781,700.00 | ₹11,398.00 |
| Gufic Biosciences Limited | GUFICBIO | ₹369.25 | ₹37,027,651,500.00 | ₹37,782.00 |
| Orchid Pharma Limited | ORCHPHARMA | ₹710.75 | ₹36,048,600,325.00 | ₹42,599.00 |
| Unichem Laboratories Limited | UNICHEMLAB | ₹506.40 | ₹35,653,497,120.00 | ₹17,743.00 |
| IOL Chemicals and Pharmaceuticals Limited | IOLCP | ₹115.76 | ₹33,978,685,520.00 | ₹10,738,156.00 |
| Solara Active Pharma Sciences Limited | SOLARA | ₹677.55 | ₹32,626,065,150.00 | ₹56,274.00 |
| Hikal Limited | HIKAL | ₹257.45 | ₹31,743,842,450.00 | ₹240,530.00 |
| Morepen Laboratories Limited | MOREPENLAB | ₹53.90 | ₹29,534,720,600.00 | ₹3,571,211.00 |
| Indoco Remedies Limited | INDOCO | ₹299.05 | ₹27,586,734,495.00 | ₹342,407.00 |
| Alembic Limited | ALEMBICLTD | ₹103.16 | ₹26,489,631,017.00 | ₹256,891.00 |
Key Executives
Assistant Company Secretary
Ms. Prachi Vichare
Gender: female
Year Born:
Company Secretary & Compliance Officer
Ms. Zeal Rupani
Gender: female
Year Born:
Chief Financial Officer, Finance Head & Executive Director
Mr. Lokesh Chandak
Gender: male
Year Born: 1987
MD & Executive Director
Mr. Milind Vasant Thatte M.B.A.
Gender: male
Year Born: 1969
FAQs about Procter & Gamble Health Limited
Who is the CEO of the company?
The CEO is Milind Vasant Thatte.
What is the current market price of the stock?
The current price is ₹6,243.50.
What is the 52-week price range?
The range is ₹4863-6739.
What is the market capitalization of the company?
The market capitalization is ₹10,363.84 crores.
What is the dividend yield?
The dividend yield is 2.96%.
What is the Price-to-Earnings (P/E) ratio?
The P/E ratio is 34.48.
Which sector does the company belong to?
The company operates in the Healthcare sector.
What does the company do?
Overview of Procter & Gamble Health Limited (ISIN: INE199A01012) is a leading Drug Manufacturers - Specialty & Generic in India. With a market capitalization of ₹10,363.84 crores and an average daily volume of 16,882 shares, it operates in the Drug Manufacturers - Specialty & Generic. The company last declared a dividend of ₹125.